New vaccine support (NVS) for YF

GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. WHO recommends that all GAVI-eligible countries at risk of yellow fever incorporate yellow fever vaccines into their national immunisation programmes. Countries at higher risk that have not to date introduced the vaccine into EPI (five of 32 GAVI-eligible countries in Africa) are encouraged to apply for GAVI support. This includes: Ethiopia, Mauritania, Sudan, South Sudan and Uganda.

Project ID
47122-1720-LBR-06B-X
Activity status
2 - Implementation
Aid type
B02 - Core contributions to multilateral institutions
% to Liberia
100.00

Organisations

Funding
The Global Alliance for Vaccination and Immunisation
Extending
World Health Organisation - core voluntary contributions account (for technical assitance)
Accountable
Federal States & Local Governments
Implementing
Federal States & Local Governments
Extending
United Nations Childrens Fund

Disbursements by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Liberia Value (USD)
2018 Q2 308,630.00 308,630.00
2017 Q4 -39,216.00 -39,216.00
2017 Q2 232,792.00 232,792.00
2016 Q4 -3,152.00 -3,152.00
2016 Q2 176,863.00 176,863.00

Commitments by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Liberia Value (USD)
2018 Q2 253,500.00 253,500.00
2017 Q2 180,000.00 180,000.00
2016 Q1 162,500.00 162,500.00

MTEF projections by fiscal year

Fiscal year Value (USD) Liberia Value (USD)
2020 97,750.00 97,750.00
2019 194,750.00 194,750.00
2018 186,500.00 186,500.00
2017 170,750.00 170,750.00
2016 81,250.00 81,250.00

CRS code %
Infectious disease control (12250) 100.0